The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of a phase I, first-in-human, dose escalation study of IMM2902 in patients with HER2-expressing advanced solid tumors.
 
Yanchun Meng
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Chuanhua Zhao
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Liming Zhu
No Relationships to Disclose
 
Zhengbo Song
No Relationships to Disclose
 
Nong Xu
No Relationships to Disclose
 
Zhen Wang
No Relationships to Disclose
 
Yanping Wang
No Relationships to Disclose
 
Yiqun Du
No Relationships to Disclose
 
Deqiang Jing
Employment - ImmuneOnco Biopharmaceuticals
Stock and Other Ownership Interests - ImmuneOnco Biopharmaceuticals
 
Dinglu Chen
Employment - ImmuneOnco Biopharmaceuticals
 
Qiaofeng Qu
Employment - ImmuneOnco Biopharmaceuticals
 
Xiwen Zhao
Employment - ImmuneOnco Biopharmaceuticals
 
Wei Li
Employment - ImmuneOnco Biopharmaceuticals
 
Qiying Lu
Employment - ImmuneOnco Biopharmaceuticals
Stock and Other Ownership Interests - ImmuneOnco Biopharmaceuticals
 
Wenzhi Tian
Employment - ImmuneOnco Biopharmaceuticals
Leadership - ImmuneOnco Biopharmaceuticals
Stock and Other Ownership Interests - ImmuneOnco Biopharmaceuticals
 
Jianming Xu
No Relationships to Disclose